This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

MediSwipe Inc. Announces Medical Marijuana Tax Brings Ten Million In Revenue For State Of Michigan

Stocks in this article: MWIP

LOS ANGELES, Feb. 7, 2013 (GLOBE NEWSWIRE) -- MediSwipe Inc. ( www.MediSwipe.com ) (OTCBB:MWIP), a patient security solutions and financial products company for the medicinal marijuana and health care industry, today announced that the state of Michigan has received in excess of ten million dollars ($10,000,000) as the result of medical marijuana legislation from tax revenues in a report released yesterday.

The annual report to the state Legislature as required by the Michigan Medical Marijuana Act shows that over $10 million in revenue was collected from administration of the state's medical marijuana program in 2012, more than double the cost of running the program. The state collected ten million in application fees from medical cannabis patients during its most recent budget year, which ended Sept. 30. After subtracting costs, Michigan netted a surplus of more than $5 million through the program, according to the new report.

Based on this information, the state could make tens of millions of dollars more by putting a system in place to regulate dispensaries and collect special taxes on cannabis sales rather than hinder the industry by cracking down on it. Revenues from the program are on the rise, increasing more than 10 percent from the $9 million recorded during the previous fiscal year, because of a rise in the overall number of patients.

"We believe that our B2B model with dispensaries, caregivers and states within legal jurisdictions will provide a meaningful revenue model for our Company. By providing digital patient records in our cloud based HIPAA compliant environment, MediPay kiosks which will provide accurate records of medicine transactions, and now merchant services directly with the states for patient applications and renewal fees, we have positioned ourselves strategically, and are poised to become the vendor of choice and leader within the sector with a residual business model. We have proven ourselves over the years as the first payment processor in this industry, and we are now bridging relationships with Michigan and other states to provide merchant services and a direct relationship for merchant processing related to patient applications and renewals to ease the backlog of paperwork via check payments. We believe this segment could create a 100 million dollar merchant portfolio if the states come onboard with our banks," stated B. Michael Friedman, CEO for MediSwipe. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs